Get the tools used by (smart)2 investors.

Shares Outstanding CAGR (3y) for Inozyme Pharma Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

INZY: Inozyme Pharma Inc

Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases. The compan...

1.00 USD
Price
USD
Fair Value
Upside
0.98 - 7.79
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Inozyme Pharma Inc's Shares Outstanding CAGR (3y):

INZYHLTH.USAIMDCDNAWINTOLMAVCNX0.0%50.0%100.0%150.0%

Performance Summary
  • Inozyme Pharma Inc's shares outstanding cagr (3y) is 39.5%

Benchmarks

Metric Usage: Shares Outstanding CAGR (3y)

Hide this widget
shares_out_cagr_3y
Slug
number
Datatype
%.%
Format
current
Default Period
Premium
Plan

Data is returned as a standard number. Suggested format is percent (e.g 0.171 => 17.1%). Please note, you need a Premium subscription to access data for shares_out_cagr_3y.

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Shares Outstanding CAGR (3y) in the valuation category include:

View Full List

Search for metric or datapoint

Shares Outstanding CAGR (3y)

Three-year compound annual growth rate in shares outstanding.

Definition of Shares Outstanding CAGR (3y)

Hide this widget
Three-year compound annual growth rate in shares outstanding.

Sector Benchmark Analysis

All rights reserved. Terms Of Use